BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,092 | -20.5% | 21,737 | +0.1% | 0.06% | -14.5% |
| Q2 2023 | $1,373 | +21.9% | 21,717 | -13.2% | 0.07% | +38.0% |
| Q1 2023 | $1,126 | +2.7% | 25,020 | +0.1% | 0.05% | -5.7% |
| Q4 2022 | $1,096 | -99.9% | 25,006 | -0.3% | 0.05% | -33.8% |
| Q3 2022 | $1,654,000 | +9.4% | 25,085 | -16.2% | 0.08% | +21.2% |
| Q2 2022 | $1,512,000 | -32.7% | 29,946 | -14.8% | 0.07% | -25.0% |
| Q1 2022 | $2,245,000 | -46.3% | 35,146 | -9.9% | 0.09% | -31.8% |
| Q4 2021 | $4,181,000 | -24.6% | 39,029 | -27.7% | 0.13% | -27.9% |
| Q3 2021 | $5,548,000 | +18.0% | 53,954 | +1.0% | 0.18% | +14.0% |
| Q2 2021 | $4,702,000 | +1549.8% | 53,433 | +394.1% | 0.16% | +1862.5% |
| Q4 2015 | $285,000 | +126.2% | 10,815 | +83.3% | 0.01% | +100.0% |
| Q3 2015 | $126,000 | -17.6% | 5,900 | +1.7% | 0.00% | -20.0% |
| Q2 2015 | $153,000 | – | 5,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |